S1387Referred to Committee

National Biotechnology Initiative Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-04-09
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Todd Young
Todd Young
Republican · IN · Senator
Votes with party: 74.6% (850 recorded votes)

Full profile: /officials/Y000064

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Committee on Health, Education, Labor, and Pensions. Hearings held.

2026-03-19

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would establish a coordinated national program to advance biotechnology research and development in the United States, likely including funding, regulatory support, and coordination between government agencies, universities, and private companies. The initiative would aim to keep America competitive in biotechnology fields like genetic medicine, synthetic biology, and biomanufacturing, potentially creating jobs and improving medical treatments for patients. The bill is currently being reviewed by the Senate health committee, which has already held hearings on the proposal.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.